These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8955618)

  • 1. Rapid diagnosis of germline p53 mutation using the enzyme mismatch cleavage method.
    Giunta C; Youil R; Venter D; Chow CW; Somers G; Lafferty A; Kemper B; Cotton RG
    Diagn Mol Pathol; 1996 Dec; 5(4):265-70. PubMed ID: 8955618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 Testing for Li-Fraumeni and Li-Fraumeni-like syndromes.
    Gonzalez K; Fong C; Buzin C; Sommer SS; Saldivar JS
    Curr Protoc Hum Genet; 2008 Apr; Chapter 10():Unit 10.10. PubMed ID: 18428420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of adrenocortical carcinoma in a child with Li-Fraumeni syndrome.
    Lin MT; Shieh JJ; Chang JH; Chang SW; Chen TC; Hsu WH
    Pediatr Blood Cancer; 2009 Apr; 52(4):541-4. PubMed ID: 19101993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours.
    Sedlacek Z; Kodet R; Kriz V; Seemanova E; Vodvarka P; Wilgenbus P; Mares J; Poustka A; Goetz P
    Br J Cancer; 1998 Apr; 77(7):1034-9. PubMed ID: 9569035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Li-Fraumeni syndrome].
    Frebourg T
    Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
    Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
    Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel germline mutation of the p53 tumor suppressor gene in a child with incidentally discovered adrenal cortical carcinoma.
    Grayson GH; Moore S; Schneider BG; Saldivar V; Hensel CH
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):341-7. PubMed ID: 7978053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Germline mutations of the p53 gene].
    Frebourg T
    Pathol Biol (Paris); 1997 Dec; 45(10):845-51. PubMed ID: 9769948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new germline TP53 gene mutation in a family with Li-Fraumeni syndrome.
    Dockhorn-Dworniczak B; Wolff J; Poremba C; Schäfer KL; Ritter J; Gullotta F; Jürgens H; Böcker W
    Eur J Cancer; 1996 Jul; 32A(8):1359-65. PubMed ID: 8869100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel p53 germline mutation in a patient with Li-Fraumeni syndrome.
    Wong SS; Lozano G; Gaff CL; Gardner RJ; Strong LC; Aittomäki K; Lindeman GJ
    Intern Med J; 2003 Dec; 33(12):621. PubMed ID: 14656244
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor-specific mutations in p53: the acid test.
    Hainaut P
    Nat Med; 2002 Jan; 8(1):21-3. PubMed ID: 11786899
    [No Abstract]   [Full Text] [Related]  

  • 13. [A method for detection of germinal mutations in the p53 tumor suppressor gene].
    Sedlácek Z; Kríz V; Seemanová E; Vlcek C; Maríková T; Mares J; Goetz P
    Cas Lek Cesk; 1996 Dec; 135(23):762-7. PubMed ID: 9005123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Li-Fraumeni syndrome family with retained heterozygosity for a germline TP53 mutation in two tumors.
    Trkova M; Foretova L; Kodet R; Hedvicakova P; Sedlacek Z
    Cancer Genet Cytogenet; 2003 Aug; 145(1):60-4. PubMed ID: 12885464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first documentation of Li-Fraumeni syndrome in Korea.
    Bang YJ; Kang SH; Kim TY; Jung CW; Oh SM; Choe KJ; Kim NK
    J Korean Med Sci; 1995 Jun; 10(3):205-10. PubMed ID: 8527048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 Tetramerization domain mutations: germline R342X and R342P, and somatic R337G identified in pediatric patients with Li-Fraumeni syndrome and a child with adrenocortical carcinoma.
    Fiszer-Maliszewska L; Kazanowska B; Padzik J;
    Fam Cancer; 2009; 8(4):541-6. PubMed ID: 19714490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three germline mutations in the TP53 gene.
    Cornelis RS; van Vliet M; van de Vijver MJ; Vasen HF; Voute PA; Top B; Khan PM; Devilee P; Cornelisse CJ
    Hum Mutat; 1997; 9(2):157-63. PubMed ID: 9067756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.
    Plummer SJ; Santibáñez-Koref M; Kurosaki T; Liao S; Noble B; Fain PR; Anton-Culver H; Casey G
    Oncogene; 1994 Nov; 9(11):3273-80. PubMed ID: 7936651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Li Fraumeni syndrome: a case with multiple primary cancers and presenting a germline p53 mutation].
    Landolsi S; Gharbi O; Zrig M; Gribaa M; Njim L; Zakhama A; Abid A; Frébourg T; Ahmed SB
    Ann Biol Clin (Paris); 2010; 68(3):346-50. PubMed ID: 20478780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 germline mutations in Li-Fraumeni syndrome.
    Santibáñez-Koref MF; Birch JM; Hartley AL; Jones PH; Craft AW; Eden T; Crowther D; Kelsey AM; Harris M
    Lancet; 1991 Dec; 338(8781):1490-1. PubMed ID: 1683921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.